BioSpace News Archive

Biotech Beach

Evofem Partners with a360 Media to Support Phexxi® Prescription Growth

Evofem Biosciences, Inc., announced an agreement between Evofem and a360 Media under which Phexxi® branded content will appear in some of the most widely read entertainment and lifestyle magazines and websites in the U.S.

July 21, 2022
·
3 min read
Biotech Beach

AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast

AXIM Biotechnologies, Inc. announced today that its CEO John Huemoeller has been featured on the Vision is More Than 20/20™ podcast.

July 21, 2022
·
3 min read
Business

Prime Therapeutics recognized as a Disability Equality Index® Best Place to Work for Disability Inclusion

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) is proud to announce its score of 90 on the Disability Equality Index ® (DEI), the world’s most comprehensive benchmarking tool measuring workplace inclusion against competitors.

July 21, 2022
·
4 min read
Business

PacBio Announces Appointment of Genomics Industry Veteran Jeff Eidel as Chief Commercial Officer

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Jeff Eidel as Chief Commercial Officer, effective August 16, 2022.

July 21, 2022
·
4 min read
Lone Star Bio

Cell and Gene Therapy Industry Comes Together for Matica Bio’s New Global Event

Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, hosted an inaugural event this week, Global Cell & Gene Day.

July 21, 2022
·
2 min read
Deals

ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value

Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), announced today that the MED Platform II fund of ArchiMed (“ArchiMed”), a leading investment firm focused exclusively on the healthcare industry, completed the acquisition of Natus.

July 21, 2022
·
3 min read
Pharm Country

Synaptogenix Announces Corporate Update Conference Call

Synaptogenix, Inc. today announced that it will hold a corporate update conference call for investors.

July 21, 2022
·
2 min read
Job Trends

Pfizer announces PREVNAR (pneumococcal 20-valent conjugate vaccine) is now available in Canada for the prevention of pneumonia and invasive pneumococcal disease in adults 18 years of age and older

Pfizer Canada ULC announced today that PREVNAR 20 (Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) is now available in Canada for the prevention of pneumonia and invasive pneumococcal disease (including sepsis, meningitis, bacteremic pneumonia, pleural empyema and bacteremia).

July 21, 2022
·
9 min read
Biotech Bay

Embolx Files 510(k) for New Soldier® High Flow Microcatheter

Embolx, Inc, today announced that the company has filed a 510(k) to the Food and Drug Administration (FDA) for its new product line of high flow microcatheters called “Soldier,” that uses the same Ultra-Thin Wall (UTW) technology initially developed for its flagship product Sniper®.

July 21, 2022
·
1 min read
Business

Imagia Canexia Health and Anwa Medical Company Enter Memorandum of Understanding to Bring Liquid Biopsy to Middle East and North Africa (MENA)

Imagia Canexia Health and Anwa Medical Co. announced that they have entered a Memorandum of Understanding to take Imagia Canexia Health’s distributed liquid biopsy testing products into Saudi Arabia and the rest of the Middle East and North Africa region.

July 21, 2022
·
4 min read